Expression of TMEM79 was found to be increased in 15 types of cancer in pan-cancer tissues, comprising uroepithelial carcinoma of the bladder, breast cancer, bile duct cancer, colon cancer, esophageal cancer, renal clear cell carcinoma, renal papillary cell carcinoma, hepatocellular cancer, lung adenocarcinoma, lung squamous carcinoma, rectal adenocarcinoma, melanoma, gastric cancer, thyroid cancer, and endometrial cancer. Here, TMEM79 is linked to clear cell renal carcinoma.